Recall: D-0436-2020

Class II - Potentially Harmful

Class IIClassification

2019-07-02Initiated

CompletedStatus

Altaire Pharmaceuticals, Inc.Firm

Product

Ofloxacin Ophthalmic Solution, USP, 0.3%, 5 mL, Rx only, Altaire Pharmaceuticals, Inc., NDC 59390-140-05

Reason

Lack of Assurance of Sterility

Distribution

U.S.A. Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.